WAY-261240
WAY-261240 is a synthetic compound that acts as a selective estrogen receptor modulator (SERM). It is primarily used in scientific research to study the effects of estrogen receptor activation and modulation in various biological systems.
Chemical Properties[edit | edit source]
WAY-261240 is characterized by its unique chemical structure, which allows it to selectively bind to estrogen receptors. The compound's molecular formula is C20H21NO3, and it has a molecular weight of 323.39 g/mol. The structure of WAY-261240 includes a core phenyl ring system with various functional groups that contribute to its binding affinity and selectivity.
Mechanism of Action[edit | edit source]
WAY-261240 functions by binding to estrogen receptors, which are nuclear hormone receptors that regulate gene expression in response to the hormone estrogen. As a SERM, WAY-261240 can act as an agonist or antagonist depending on the tissue type. This dual action is due to its ability to induce conformational changes in the estrogen receptor, influencing the recruitment of coactivators or corepressors.
Pharmacological Effects[edit | edit source]
In preclinical studies, WAY-261240 has been shown to exhibit tissue-selective effects. It can mimic the effects of estrogen in certain tissues, such as bone and the cardiovascular system, while blocking estrogenic effects in other tissues, such as the breast and uterus. This makes it a valuable tool for studying the differential effects of estrogen receptor activation.
Research Applications[edit | edit source]
WAY-261240 is used extensively in research to explore the role of estrogen receptors in various physiological and pathological processes. It is particularly useful in studies investigating the potential therapeutic applications of SERMs in conditions like osteoporosis, breast cancer, and cardiovascular disease.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of WAY-261240 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers handling WAY-261240 must adhere to safety protocols to minimize exposure and potential risks.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
